Alpine Clinical Research Center

Main menu

Skip to content
  • Home
  • Current Research Studies
  • For Participants
  • For Sponsors
  • Contact

Trial Archives: Completed

Post navigation

← Older trials
Newer trials →

Rheumatoid Arthritis

- April 20, 2015

Investigational Medicine for COPD

- October 6, 2014

Parkinson’s Disease

- September 3, 2014

Investigational Medicine for prevention of Migraine Headaches

- March 17, 2014

Oral Investigational Medicine for the Treatment of Mild to Moderate Alzheimer’s Disease

- December 5, 2013

New oral study medication for patients with Post Herpetic Neuralgia (PHN)

- December 5, 2013

New Investigational Medication for patients with Chronic Obstructive Pulmonary Disease with a history of cardiac issues.

- December 5, 2013

New Study Medication for Patients with Secondary Progressive Multiple Sclerosis

- December 5, 2013

Newly Approved Medication for Multiple Sclerosis

- December 5, 2013

New Investigational Medication for patients with moderate to severe COPD (chronic obstructive pulmonary disease)

- September 17, 2012

New Investigational Medication for Postherpetic Neuralgia (PHN/Shingles)

- September 17, 2012

Newly approved medication for Multiple Sclerosis

- June 29, 2012

Investigational medication for pediatric patients with Autism, Asperger’s disorder, or Pervasive developmental disorder.

- May 8, 2012

Newly approved medication for subjects in early stages of treatment for Relapsing Remitting Multiple Sclerosis

- May 8, 2012

Protocol: F-AV-45-A17 PET scan using an investigational radioactive drug to help determine the likely cause of cognitive decline.

- May 8, 2012

Post navigation

← Older trials
Newer trials →

Our CenterWatch Profile

Alpine Clinical Research Center on CenterWatch

Alpine Clinical Research Center - 3434 47th Street, Suite 201 - Boulder, CO 80301
phone: 303.443.7229 | fax: 303.443.7748 | email: info@alpineresearch.com
site by: Lenfert Design